Prevalence and clinical outcomes of patients with multiple potential causes of syncope

Mayo Clin Proc. 2003 Apr;78(4):414-20. doi: 10.4065/78.4.414.

Abstract

Objective: To determine the prevalence, predictors, and prognosis of patients with multiple potential causes of syncope.

Patients and methods: This is a retrospective cohort study with prospective follow-up of consecutive patients with syncope of uncertain cause who were referred to the electrophysiology service for syncope evaluation from January 1, 1996, through December 31, 1998. The main outcome measures were prevalence of multiple potential causes of syncope, survival of patients with multiple potential causes of syncope compared with survival of patients with a single cause, and clinical predictors of multiple potential causes of syncope.

Results: A total of 987 patients were studied (mean +/- SD age, 58.0 +/- 21.4 years; male, 550 [55.7%]). Multiple potential causes were present in 182 patients (18.4%). Patients with multiple potential causes of syncope had a lower survival rate at 4 years, 73.1% (95% confidence interval, 64.6%-82.8%), vs those with a single cause, 89.3% (95% confidence interval, 86.4%-92.2%) (P < .001). Multivariate predictors of multiple potential causes were older age, atrial fibrillation, use of cardiac medications, and New York Heart Association classification II, III, and IV.

Conclusion: Of the patients evaluated for syncope, 18.4% had multiple potential causes. The presence of multiple potential causes was an independent predictor of increased mortality among patients with syncope.

MeSH terms

  • Age Factors
  • Atrial Fibrillation / complications*
  • Cardiovascular Agents / adverse effects*
  • Cardiovascular Diseases / classification
  • Cardiovascular Diseases / complications*
  • Carotid Sinus / physiopathology
  • Databases, Factual
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Outcome Assessment, Health Care
  • Predictive Value of Tests
  • Prevalence
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Recurrence
  • Retrospective Studies
  • Survival Analysis
  • Syncope / diagnosis
  • Syncope / epidemiology*
  • Syncope / etiology*
  • Syncope / physiopathology
  • United States / epidemiology

Substances

  • Cardiovascular Agents